Biomarker test-maker Cleveland HeartLab has closed an $18.4 million series B round of funding, which was led by two Boston-area investors. The size of the round is a testament to the explosive growth ...

Biomarker testing firm Cleveland HeartLab is still growing fast, and it doesn’t plan on slowing down anytime soon. The three-year-old startup has just tacked an additional $14.7 million in fresh ...

Cleveland HeartLab has agreed to be acquired by Quest Diagnostics, a Fortune 500 medical testing company based in New Jersey. The deal should help the Cleveland Clinic spinout company accelerate its ...

A Cleveland Clinic spinoff company formed in late 2009 as the newest entry in the field of cardiovascular technology is now poised for more growth. Cleveland HeartLab president and chief executive ...

If you want to make a fast-growing company grow even faster, giving it nearly $15 million might help. Cleveland HeartLab Inc. has raised $14.7 million in venture capital in a deal led by Mutual ...

SECAUCUS, N.J. and CLEVELAND, Dec. 1, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) today announced that it has completed its previously announced acquisition of Cleveland HeartLab. Quest will ...

After hitting several roadblocks in getting grants from the National Institutes of Health and the National Science Foundation, Robert Petrocelli and Dr. Jonathan Elion thought it was time to take ...

CLEVELAND, Ohio - Quest Diagnostics signed a deal with Cleveland Clinic spinoff Cleveland HeartLab to acquire the company before the end of the year. Cleveland HeartLab, a cardiovascular diagnostic ...

Medtech startup HeartLab has today announced $3.5m has been raised through a funding round led by Silicon Valley’s Founders Fund that will supercharge its entry into the US market early next year.